The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis

被引:67
作者
Mikula, M
Gotzmann, J
Fischer, ANM
Wolschek, MF
Thallinger, C
Schulte-Hermann, R
Beug, H
Mikulits, W
机构
[1] Univ Vienna, Inst Canc Res, A-1090 Vienna, Austria
[2] Vienna Gen Hosp, Dept Clin Pharmacol, Sect Expt Oncol, A-1090 Vienna, Austria
[3] Res Inst Mol Pathol, A-1030 Vienna, Austria
关键词
c-Fos; hepatocytes; cell death; tumour suppressor;
D O I
10.1038/sj.onc.1206781
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocytes adopt an invasive and metastatic phenotype caused by the cooperation of transforming growth factor (TGF)-beta and oncogenic Ha-Ras. In the initial phase of this process, c-Fos is rapidly induced by TGF-beta, but then decreases to undetectable levels. Here, we investigated the functional implications of c-Fos activation and its contribution to hepatocellular tumorigenesis. By employing conditional c-Fos expression, we observed that continuous activation of c-Fos and consequently AP-1 activity leads to depolarization of differentiated murine epithelial hepatocytes. Most remarkably, this change in morphology was associated with inhibition of proliferation and induction of cell death. Coexpression of antiapoptotic Bcl-X-L or scavenging of reactive oxygen species was sufficient to prevent the c-Fos-mediated phenotype. In contrast, the cooperation of c-Fos with oncogenic Ha-Ras or a Ras mutant selectively activating the MAPK pathway even enhanced c-Fos-induced effects. Showing the negative role in hepatocellular tumorigenesis, c-Fos repressed oncogenic Ras-driven anchorage-independent growth in vitro and strongly suppressed tumour formation in vivo. Taken together, we demonstrate that c-Fos modulates plasticity of epithelial hepatocytes and acts tumour suppressive in neoplastic hepatocytes by stimulating cell cycle inhibition and cell death.
引用
收藏
页码:6725 / 6738
页数:14
相关论文
共 83 条
[51]   Liver regeneration .7. Prometheus' myth revisited: Transgenic mice as a powerful tool to study liver regeneration [J].
Pistoi, S ;
Morello, D .
FASEB JOURNAL, 1996, 10 (08) :819-828
[52]  
Preston GA, 1996, MOL CELL BIOL, V16, P211
[53]   Expression of p27KIP1 and p21WAF1/CIP1 in primary hepatocellular carcinoma:: Clinicopathologic correlation and survival analysis [J].
Qin, LF ;
Ng, IOL .
HUMAN PATHOLOGY, 2001, 32 (08) :778-784
[54]   Hepatocyte growth factor activates the AP-1 complex: a comparison between normal and transformed rat hepatocytes [J].
Rahmani, M ;
Nadori, F ;
Durand-Schneider, AM ;
Lardeux, B ;
Bernuau, D .
JOURNAL OF HEPATOLOGY, 1999, 30 (05) :916-925
[55]  
Ravazoula P, 2002, ANTICANCER RES, V22, P1799
[56]   ACTIVATION OF AN INDUCIBLE C-FOSER FUSION PROTEIN CAUSES LOSS OF EPITHELIAL POLARITY AND TRIGGERS EPITHELIAL-FIBROBLASTOID CELL CONVERSION [J].
REICHMANN, E ;
SCHWARZ, H ;
DEINER, EM ;
LEITNER, I ;
EILERS, M ;
BERGER, J ;
BUSSLINGER, M ;
BEUG, H .
CELL, 1992, 71 (07) :1103-1116
[57]   Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras [J].
RodriguezViciana, P ;
Warne, PH ;
Khwaja, A ;
Marte, BM ;
Pappin, D ;
Das, P ;
Waterfield, MD ;
Ridley, A ;
Downward, J .
CELL, 1997, 89 (03) :457-467
[58]  
Rossmanith W, 2001, MICROSC RES TECHNIQ, V52, P430, DOI 10.1002/1097-0029(20010215)52:4<430::AID-JEMT1028>3.0.CO
[59]  
2-3
[60]  
RUTHER U, 1989, ONCOGENE, V4, P861